Inflammatory cytokine signaling modulation

"Inflammatory cytokine signaling modulation" refers to the alteration or regulation of the signaling pathways used by inflammatory cytokines, which are secreted proteins such as interleukins (ILs), tumor necrosis factors (TNFs), and interferons (IFNs), among others. These pathways (e.g., NF-κB, MAPK, Jak-STAT) are central to immune and inflammatory responses, and various drugs are developed to modulate these pathways in diseases such as rheumatoid arthritis, psoriasis, and cancer. However, this term does not denote a discrete receptor, enzyme, or protein, but rather an entire network or process, making it non-canonical and unsuitable for mapping as a single molecular target.